Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV
Abstract Introduction Transient viremia can occur in people with human immunodeficiency virus (HIV), often referred to as people with HIV (PWH), and is sometimes related to poor adherence to antiretroviral therapy (ART). Guidelines recommend achieving virologic resuppression with existing ART regime...
Saved in:
| Main Authors: | Anton Pozniak, Chloe Orkin, Yazdan Yazdanpanah, Axel Baumgarten, Karam Mounzer, Michelle L. D’Antoni, Hailin Huang, Hui Liu, Kristen Andreatta, Laurie A. VanderVeen, Christian Callebaut, Jason T. Hindman, José R. Arribas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-025-01153-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Aleksandra Berkan-Kawińska, et al.
Published: (2024-07-01) -
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
by: Hernando Knobel, et al.
Published: (2023-12-01) -
Successful viral suppression in a two-year-old child with human immunodeficiency virus infection treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Coskun Ekemen, et al.
Published: (2025-07-01) -
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study
by: Helena Kwakwa, et al.
Published: (2025-03-01) -
Health Economics Evaluation of Bictegravir/Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in China
by: Wang W, et al.
Published: (2025-05-01)